A detailed history of Toronto Dominion Bank transactions in United Therapeutics Corp stock. As of the latest transaction made, Toronto Dominion Bank holds 5,546 shares of UTHR stock, worth $2.06 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,546
Previous 5,546 -0.0%
Holding current value
$2.06 Million
Previous $1.99 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$311.04 - $363.55 $317,571 - $371,184
1,021 Added 22.56%
5,546 $1.99 Million
Q2 2024

Aug 14, 2024

BUY
$228.26 - $319.04 $8,445 - $11,804
37 Added 0.82%
4,525 $1.44 Million
Q1 2024

May 14, 2024

SELL
$210.76 - $249.51 $341,431 - $404,206
-1,620 Reduced 26.52%
4,488 $1.03 Million
Q4 2023

Feb 13, 2024

SELL
$214.88 - $256.94 $2.11 Million - $2.53 Million
-9,834 Reduced 61.69%
6,108 $1.34 Million
Q3 2023

Feb 14, 2024

SELL
$211.82 - $248.24 $461,555 - $540,914
-2,179 Reduced 12.02%
15,942 $3.6 Million
Q3 2023

Nov 14, 2023

SELL
$211.82 - $248.24 $461,555 - $540,914
-2,179 Reduced 12.02%
15,942 $3.6 Million
Q2 2023

Feb 14, 2024

BUY
$205.19 - $232.99 $2.46 Million - $2.8 Million
12,013 Added 196.68%
18,121 $4 Million
Q2 2023

Aug 10, 2023

BUY
$205.19 - $232.99 $878,828 - $997,896
4,283 Added 30.95%
18,121 $4 Million
Q1 2023

May 11, 2023

BUY
$212.99 - $276.17 $2.46 Million - $3.19 Million
11,538 Added 501.65%
13,838 $3.1 Million
Q4 2022

Feb 07, 2023

SELL
$205.95 - $280.43 $494,280 - $673,032
-2,400 Reduced 51.06%
2,300 $639,000
Q3 2022

Nov 09, 2022

BUY
$203.3 - $244.17 $955,510 - $1.15 Million
4,700 New
4,700 $984,000
Q1 2022

May 09, 2022

SELL
$166.16 - $213.96 $11.6 Million - $15 Million
-70,000 Closed
0 $0
Q4 2021

Feb 04, 2022

BUY
$184.32 - $216.08 $12.9 Million - $15.1 Million
70,000 New
70,000 $15.1 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.9B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Toronto Dominion Bank Portfolio

Follow Toronto Dominion Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Toronto Dominion Bank, based on Form 13F filings with the SEC.

News

Stay updated on Toronto Dominion Bank with notifications on news.